Gimv (EBR:GIMB) | WebDisclosure

Basculer en Français

8295	Companies
114846	Keywords
55288	Articles
62438	Press releases

REGULATED PRESS RELEASE

published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv veräußert Mehrheitsbeteiligung am ambulanten Rehabilitationsspezialisten rehaneo an Fremman Capital
Gimv verkauft Mehrheitsbeteiligung an rehaneo an Fremman Capital. rehaneo ist ein führender Anbieter von ambulanter Rehabilitation, Nachsorge, Prävention und Gesundheitsmanagement

Gimv Rehaneo Fremman Capital Ambulante Rehabilitation Gesundheitsmanagement
BRIEF

published on 10/28/2024 at 17:50, 23 days 17 hours ago

Gimv Invests in Kivu Bioscience's $92M Series A Funding

Oncology Series A ADC Funding Gimv Investment Kivu Bioscience
BRIEF

published on 10/28/2024 at 17:50, 23 days 17 hours ago

Gimv s'engage dans le financement de Kivu Bioscience pour les conjugués anticorps-médicaments

Gimv Levée De Fonds Oncologie Kivu Bioscience Anticorps-médicaments
REGULATED PRESS RELEASE

published on 10/28/2024 at 17:45, 23 days 17 hours ago

Gimv participates in a $92M Series A financing round at Kivu Bioscience to advance next-gen antibody-drug conjugates
Gimv participates in $92M Series A financing round at Kivu Bioscience to advance next-gen antibody-drug conjugates. Novo Holdings leads the round

Gimv Antibody-drug Conjugates Series A Kivu Bioscience Novo Holdings
REGULATED PRESS RELEASE

published on 10/28/2024 at 17:45, 23 days 17 hours ago

Gimv participates in a $92M Series A financing round at Kivu Bioscience to advance next-gen antibody-drug conjugates
Gimv participe à une levée de fonds de série A de 92 M$ chez Kivu Bioscience pour faire avancer les conjugués médicament-anticorps de nouvelle génération

Gimv Levée De Fonds Oncologie Kivu Bioscience Conjugés Médicament-anticorps
REGULATED PRESS RELEASE

published on 10/28/2024 at 17:45, 23 days 17 hours ago

Gimv neemt deel aan Series A financieringsronde van $92M bij Kivu Bioscience voor de ontwikkeling van next-gen kanker bestrijdende antibody-geneesmiddelen combinaties
Gimv neemt deel aan Series A financieringsronde van $92M bij Kivu Bioscience voor ontwikkeling next-gen kanker bestrijdende antibody-geneesmiddelen combinaties

Gimv Oncologie Antibody-drug Conjugates Series A Kivu Bioscience
BRIEF

published on 10/16/2024 at 07:50, 1 month 5 days ago

Brouwerij Martens Acquires United Dutch Breweries for Global Expansion

Acquisition Innovation Global Expansion Sustainability Brewing Industry
BRIEF

published on 10/16/2024 at 07:50, 1 month 5 days ago

Brouwerij Martens acquiert United Dutch Breweries pour une expansion mondiale

Acquisition Innovation Durabilité Expansion Mondiale Brasserie
REGULATED PRESS RELEASE

published on 10/16/2024 at 07:45, 1 month 5 days ago

Brouwerij Martens acquires United Dutch Breweries with a purpose of further joint global expansion
Brouwerij Martens acquires United Dutch Breweries for joint global expansion. The acquisition aims to leverage each company's strengths for further growth and value creation

Acquisition Global Expansion Brouwerij Martens United Dutch Breweries Brewery
REGULATED PRESS RELEASE

published on 10/16/2024 at 07:45, 1 month 5 days ago

Brouwerij Martens acquires United Dutch Breweries with a purpose of further joint global expansion
Brouwerij Martens acquires United Dutch Breweries for global expansion. Strategic partnership for growth and synergy. Belgium. Netherlands

Acquisition Global Expansion Belgium Brouwerij Martens United Dutch Breweries

Accesswire

Published on 11/21/2024 at 10:03, 1 hour 34 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 1 hour 37 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 2 hours 37 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 11 hours 2 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 11 hours 12 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 11:01, 35 minutes ago

Original-Research: SMT Scharf AG (von Montega AG): Kaufen
Published on 11/21/2024 at 11:00, 37 minutes ago

First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Published on 11/21/2024 at 10:56, 40 minutes ago

ABO Energy closes sale for two Battery Projects in South Africa
Published on 11/21/2024 at 10:30, 1 hour 7 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 1 hour 32 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO

Les Echos

Published on 11/21/2024 at 06:58, 4 hours 39 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 4 hours 39 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 4 hours 39 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 15 hours 29 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 16 hours 17 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE